Skip to main content
Log in

Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis

  • Review Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

This study aimed to investigate whether paraoxonase 1 (PON1) Q192R and L55M polymorphisms are associated with susceptibility to amyotrophic lateral sclerosis (ALS). We conducted a meta-analysis of the associations between the PON1 Q192R and L55M polymorphisms and ALS. A total of 2,831 patients and 3,123 controls from eight studies of the PON1 Q192R polymorphism and seven studies of the PON1 L55M T polymorphism were considered for this study. Meta-analysis showed no association between ALS and the PON1 192R allele (OR = 1.052, 95 % CI = 0.923–1.207, p = 0.447), and the PON1 55M allele (OR = 1.015, 95 % CI = 0.884–1.164, p = 0.837) in all study subjects. Similarly, no association was found between ALS and the PON1 Q192R and L55M polymorphisms using recessive, dominant or homozygote contrast models. Stratification by ethnicity indicated no association between ALS and the PON1 192R allele (OR = 1.058, 95 % CI = 0.910–1.231, p = 0.464) and the PON1 55M allele (OR = 1.027, 95 % CI = 0.889–1.185, p = 0.721) in the European population. This meta-analysis showed lack of associations between PON1 Q192R and L55M polymorphisms and susceptibility to ALS in the European population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Monk PN, Shaw PJ (2006) ALS: life and death in a bad neighborhood. Nat Med 12(8):885–887

    Article  CAS  PubMed  Google Scholar 

  2. Chen S, Sayana P, Zhang X, Le W (2013) Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener 8(1):28

    Article  PubMed Central  PubMed  Google Scholar 

  3. Schymick JC, Talbot K, Traynor BJ (2007) Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 16:R233–R242

    Article  CAS  PubMed  Google Scholar 

  4. Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180(2):242–247

    Article  CAS  PubMed  Google Scholar 

  5. Qureshi MM, Hayden D, Urbinelli L, Ferrante K, Newhall K, Myers D et al (2006) Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler 7(3):173–182

    Article  PubMed  Google Scholar 

  6. Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C et al (2003) The DNA sequence of human chromosome 7. Nature 424(6945):157–164

    Article  CAS  PubMed  Google Scholar 

  7. Scacchi R, Corbo RM, Rickards O, De Stefano GF (2003) New data on the world distribution of paraoxonase (PON1 Gln 192→Arg) gene frequencies. Hum Biol 75(3):365–373

    Article  CAS  PubMed  Google Scholar 

  8. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 14(3):334–336

    Article  CAS  PubMed  Google Scholar 

  9. Chen Y, Huang R, Chen K, Song W, Yang Y, Zhao B et al (2012) Association analysis of PON polymorphisms in sporadic ALS in a Chinese populationl. Neurobiol Aging 33(12):2949e1

    Article  Google Scholar 

  10. Ricci C, Battistini S, Cozzi L, Benigni M, Origone P, Verriello L et al (2011) Lack of association of PON polymorphisms with sporadic ALS in an Italian population. Neurobiol Aging 32(3):552

    Article  PubMed  Google Scholar 

  11. Wills AM, Landers JE, Zhang H, Richter RJ, Caraganis AJ, Cudkowicz ME et al (2008) Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Neurology 70(12):929–934

    Article  CAS  PubMed  Google Scholar 

  12. Cronin S, Greenway MJ, Prehn JH, Hardiman O (2007) Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 78(9):984–986

    Article  PubMed Central  PubMed  Google Scholar 

  13. Slowik A, Tomik B, Wolkow PP, Partyka D, Turaj W, Malecki MT et al (2006) Paraoxonase gene polymorphisms and sporadic ALS. Neurology 67(5):766–770

    Article  CAS  PubMed  Google Scholar 

  14. Landers JE, Shi L, Cho TJ, Glass JD, Shaw CE, Leigh PN et al (2008) A common haplotype within the PON1 promoter region is associated with sporadic ALS. Amyotroph Lateral Scler 9(5):306–314

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Morahan JM, Yu B, Trent RJ, Pamphlett R (2007) Genetic susceptibility to environmental toxicants in ALS. Am J Med Genet B Neuropsychiatr Genet 144B(7):885–890

    Article  CAS  PubMed  Google Scholar 

  16. Kasperaviciute D, Weale ME, Shianna KV, Banks GT, Simpson CL, Hansen VK et al (2007) Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain 130(Pt 9):2292–2301

    Article  PubMed  Google Scholar 

  17. Morahan JM, Yu B, Trent RJ, Pamphlett R (2007) A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. Neurotoxicology 28(3):532–540

    Article  CAS  PubMed  Google Scholar 

  18. Nath SK, Harley JB, Lee YH (2005) Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 118(2):225–234

    Article  CAS  PubMed  Google Scholar 

  19. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2006) Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 27(2):157–161

    Article  CAS  PubMed  Google Scholar 

  20. Lee YH, Witte T, Momot T, Schmidt RE, Kaufman KM, Harley JB et al (2005) The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum 52(12):3966–3974

    Article  CAS  PubMed  Google Scholar 

  21. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558

    Article  PubMed  Google Scholar 

  22. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  CAS  PubMed  Google Scholar 

  23. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Chapuis J, Boscher M, Bensemain F, Cottel D, Amouyel P, Lambert JC (2009) Association study of the paraoxonase 1 gene with the risk of developing Alzheimer’s disease. Neurobiol Aging 30(1):152–156

    Article  CAS  PubMed  Google Scholar 

  25. Wills AM, Cronin S, Slowik A, Kasperaviciute D, Van Es MA, Morahan JM et al (2009) A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology 73(1):16–24

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Conflict of interest

The authors report no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young Ho Lee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, Y.H., Kim, JH., Seo, Y.H. et al. Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis. Neurol Sci 36, 11–20 (2015). https://doi.org/10.1007/s10072-014-1979-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1979-y

Keywords

Navigation